💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

VistaGen prices stock offering at $1.75; shares down 7%

Published 08/31/2017, 09:43 AM
© Reuters.  VistaGen prices stock offering at $1.75; shares down 7%
VTGN
-
  • VistaGen Therapeutics (VTGN -6.6%) prices its public offering of 1,371,430 shares of common stock and warrants to purchase up to 1,892,572 shares of common at a combined price of $1.75.
  • Each common share is being offered with 1.0128 Series A1 Warrants and 0.3672 of a Series A2 Warrant. Each complete five-year warrant is exercisable at $1.82 per common share.
  • Gross proceeds should be ~$2.4M. Closing date is September 6.
  • Net proceeds will be used for general corporate purposes.
  • Now read: Dynavax: Date With Destiny


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.